For women experiencing depression due to the cancer and hot flashes due to tamoxifen it is important not to prescribe SSRIs and SNRIs, which are moderate to strong CYP2D6 inhibitors and decrease endoxifen levels by 50–72% [103]. The gene discussed is CYP2D6; the disease is depressive disorder.